Literature DB >> 1972008

Reversal of mydriasis by dapiprazole.

R W Allinson1, D S Gerber, S Bieber, B L Hodes.   

Abstract

The effect of topical dapiprazole, an alpha-adrenergic receptor blocker, in reversing mydriasis was studied in 50 subjects who received tropicamide 1% and phenylephrine 2.5%. There was a significant difference in the decrease in pupil size between the eye that received dapiprazole and the control eye. This study suggests that dapiprazole 0.5% eye drops are effective and safe in reversing mydriasis after instillation of tropicamide 1% and phenylephrine 2.5%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972008

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  4 in total

1.  Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.

Authors:  S Nakamura; T Taniguchi; F Suzuki; Y Akagi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  The additive miotic effects of dapiprazole and pilocarpine.

Authors:  O Geyer; A Loewenstein; B Shalmon; M Neudorfer; M Lazar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

3.  Comparison of the effects on pupil size and accommodation of three regimens of topical dapiprazole.

Authors:  C S Wilcox; J F Heiser; A M Crowder; N J Wassom; B B Katz; J L Dale
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

Review 4.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.